Oscar Matthews
Cardiovascular Disease · Vista, CANPI 1053300673
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $8,458 of the $10,215 with a category attached, or 82.8%. 26 manufacturers reported payments, led by Medtronic at 28.8% of the total. Reporting peaked in 2019 at $5,447 and has fallen 98.3% since, to $95 in 2025.
Across 257 payments — averaging $39.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- Abbott$3K
- Boston Scientific$1K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$707
- Novo Nordisk$534
- Biotronik Inc.$407
- plus $2K from 20 others
What the payments were for
- Travel & lodging$1,74317%
- Food & beverage$8,45883%
- Education$140%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 35 | $2,938 |
| Abbott | 25 | $2,523 |
| Boston Scientific | 12 | $1,106 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 64 | $707 |
| Novo Nordisk | 36 | $534 |
| Biotronik Inc. | 11 | $407 |
| Cardiovascular Systems Inc. | 10 | $387 |
| Johnson & Johnson | 13 | $203 |
| Cardinal Health 200 LLC | 2 | $203 |
| Biom'up France SAS | 2 | $166 |
| E.r. Squibb & Sons, L.L.C. | 6 | $130 |
| Novartis | 8 | $128 |
| Boehringer Ingelheim | 7 | $127 |
| Merck | 6 | $123 |
| Abiomed | 4 | $108 |
| Biotronik NRO, Inc. | 1 | $95 |
| AstraZeneca | 4 | $76 |
| Bayer | 3 | $71 |
| ZOLL Circulation Inc | 1 | $64 |
| Amarin Pharma, Inc. | 1 | $24 |
| Arbor Pharmaceuticals, Inc. | 1 | $18 |
| Alnylam Pharmaceuticals Inc. | 1 | $17 |
| Itamar Medical Inc | 1 | $17 |
| Actelion Pharmaceuticals US, Inc. | 1 | $16 |
| Terumo Medical Corporation | 1 | $15 |
| GE HealthCare | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Resolute$1,519
- Xience V coronary stent system$992
- GENERAL - THERAPIES$314
- LUX-DX$250
- EnSite Precision Cardiac Mapping System$249
- EluNIR Radaforolimus Eluting Coronary Stent System$203
- Evera$144
- HemoBlast Bellows$138
- Xience Sierra Coronary Stent System$131
- Quadra Assura CRT Defibrillator$130
- Azure$128
- Coronary Orbital Atherectomy System$115
- RESONATE$112
- Confirm Rx$102
- ASSURITY$102
How this compares
$10,215 in reported general payments places this provider in the 75th percentile of 2,184 cardiovascular disease providers in California.
Other cardiovascular disease in Vista
- Ted LoveHillsborough$102.8M
- Paul KurthSanta Barbara$6.1M
- Jason RogersSacramento$4.4M
- Matthew BudoffTorrance$3.6M
- Eric Topolla Jolla$2.2M
- Cathleen Bairey-MerzLos Angeles$1.2M
- Gagan SinghSacramento$1.2M
- Pam Taubla Jolla$1.2M
- Wilber SuStanford$1.1M
- Thomas SmithSacramento$942K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.